gabapentin
Generic: gabapentin
Labeler: aphena pharma solutions - tennessee, llcDrug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
aphena pharma solutions - tennessee, llc
Dosage Form
TABLET
Routes
Active Ingredients
gabapentin 600 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71610-621
Product ID
71610-621_bc931d95-28ae-405b-ad93-e1fe0b51eab9
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214957
Listing Expiration
2026-12-31
Marketing Start
2021-10-01
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71610621
Hyphenated Format
71610-621
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA214957 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 600 mg/1
Packaging
- 15 TABLET in 1 BOTTLE (71610-621-15)
- 30 TABLET in 1 BOTTLE (71610-621-30)
- 45 TABLET in 1 BOTTLE (71610-621-45)
- 60 TABLET in 1 BOTTLE (71610-621-53)
- 90 TABLET in 1 BOTTLE (71610-621-60)
- 120 TABLET in 1 BOTTLE (71610-621-70)
- 135 TABLET in 1 BOTTLE (71610-621-73)
- 180 TABLET in 1 BOTTLE (71610-621-80)
- 270 TABLET in 1 BOTTLE (71610-621-92)
- 360 TABLET in 1 BOTTLE (71610-621-94)
Packages (10)
71610-621-15
15 TABLET in 1 BOTTLE (71610-621-15)
71610-621-30
30 TABLET in 1 BOTTLE (71610-621-30)
71610-621-45
45 TABLET in 1 BOTTLE (71610-621-45)
71610-621-53
60 TABLET in 1 BOTTLE (71610-621-53)
71610-621-60
90 TABLET in 1 BOTTLE (71610-621-60)
71610-621-70
120 TABLET in 1 BOTTLE (71610-621-70)
71610-621-73
135 TABLET in 1 BOTTLE (71610-621-73)
71610-621-80
180 TABLET in 1 BOTTLE (71610-621-80)
71610-621-92
270 TABLET in 1 BOTTLE (71610-621-92)
71610-621-94
360 TABLET in 1 BOTTLE (71610-621-94)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bc931d95-28ae-405b-ad93-e1fe0b51eab9", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310433"], "spl_set_id": ["7f579665-afb7-4227-98c1-2eafee650504"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BOTTLE (71610-621-15)", "package_ndc": "71610-621-15", "marketing_start_date": "20220124"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (71610-621-30)", "package_ndc": "71610-621-30", "marketing_start_date": "20211202"}, {"sample": false, "description": "45 TABLET in 1 BOTTLE (71610-621-45)", "package_ndc": "71610-621-45", "marketing_start_date": "20211202"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-621-53)", "package_ndc": "71610-621-53", "marketing_start_date": "20220124"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-621-60)", "package_ndc": "71610-621-60", "marketing_start_date": "20211202"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (71610-621-70)", "package_ndc": "71610-621-70", "marketing_start_date": "20220124"}, {"sample": false, "description": "135 TABLET in 1 BOTTLE (71610-621-73)", "package_ndc": "71610-621-73", "marketing_start_date": "20211202"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-621-80)", "package_ndc": "71610-621-80", "marketing_start_date": "20211217"}, {"sample": false, "description": "270 TABLET in 1 BOTTLE (71610-621-92)", "package_ndc": "71610-621-92", "marketing_start_date": "20211202"}, {"sample": false, "description": "360 TABLET in 1 BOTTLE (71610-621-94)", "package_ndc": "71610-621-94", "marketing_start_date": "20220124"}], "brand_name": "GABAPENTIN", "product_id": "71610-621_bc931d95-28ae-405b-ad93-e1fe0b51eab9", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "71610-621", "generic_name": "Gabapentin", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "600 mg/1"}], "application_number": "ANDA214957", "marketing_category": "ANDA", "marketing_start_date": "20211001", "listing_expiration_date": "20261231"}